Sentence examples for a pilot screening of from inspiring English sources

As a proof of concept, we carried out a pilot screening of the Microsource Library as described above and the results are plotted in Fig. 6.

To identify small molecules that, in combination with BRD4770, can promote cell death even in the absence of p53, we performed a pilot screening of known probes and drugs that target cancer-relevant pathways using two assay readouts of cell viability in PANC-1 cells.

A pilot screen of a pharmacologically characterized compound library identified two thiol-modifying compounds as authentic NDM-1 inhibitors: p-chloromecuribenzoate (p-CMB) and nitroprusside.

The TR FRET assay is suitable for high-throughput screening (HTS), as shown by performing a pilot screen of the National Institutes of Health NIH Clinical Collection Libraryry in a 384-well plate format.

Through a pilot screen of 2802 compounds from the National Cancer Institute (NCI) chemical libraries, we identified aclacinomycin (Acm) as a compound that preferentially affects ER function.

A pilot screen of an unbiased chemical library identified novel compounds that inhibited processing of fluorescent lipid analogues in live zebrafish larvae.

In order to find lens and retinal alterations, a pilot screen of 299 families of the F3 generation of ENU-treated adult zebrafish was carried out.

Here we report the results of a pilot screen of a non-biased chemical library through which we identified 7 novel compounds that inhibited the absorption of fluorescent lipid analogues.

Preliminary results of a pilot screen of 3,840 compounds from the MLSCN library (http://mli.nih.gov/mli/) have been reported (http://pubchem.ncbi.nlm.nih.gov/assay/assay.cgi aid=686&loc=ea_ras; http://pubchem.ncbi.nlm.nih.gov/assay/assay.cgi aid=691&loc=ea_ras).cgi aid=691&loc=ea_ras

The KSp21-based assay was validated in a pilot screen of the NINDS collection of 1,040 bioactive compounds (ICCB Longwood, Harvard Medical School).

A pilot screen of 12,800 compounds identifies two molecules that restore reporter activity in a dose-dependent manner and that are subsequently validated in secondary genetic screens.